GLAND — Gland Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Gland Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	32,427	37,628	19,388	29,522	34,328
Net Total Accounts Receivable
Net Total Receivables	13,599	11,381	18,908	20,581	18,914
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	58,521	69,008	56,452	67,829	75,268
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16,804	17,361	38,302	39,439	44,320
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	78,336	87,775	106,612	112,249	125,108
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,820	7,291	13,984	15,648	16,084
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	6,760	8,188	19,374	20,742	21,529
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	71,576	79,587	87,238	91,507	103,580
Total Liabilities & Shareholders' Equity	78,336	87,775	106,612	112,249	125,108
Total Common Shares Outstanding